LCTX US Equity
Lineage Cell Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 876343 · FY ends Dec 31$1.10
+0.04 (+3.77%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 29.6M |
| % of shares out | 11.7% |
| Days to cover | 26.2 |
| Δ vs 2026-07-15 | -1.0% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 29,561,507 | -1.0% | 1,128,474 | 26.2 |
| 2026-07-15 | 29,867,928 | +6.0% | 862,087 | 34.6 |
| 2026-06-30 | 28,185,804 | +10.3% | 3,379,386 | 8.3 |
| 2026-06-15 | 25,555,170 | -2.0% | 1,109,741 | 23.0 |
| 2026-05-29 | 26,083,430 | +0.7% | 1,045,038 | 25.0 |
| 2026-05-15 | 25,915,824 | +1.3% | 1,546,127 | 16.8 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
